Publications by authors named "Gilberto Amorim"

Claim this Profile
T
The burden of systemic therapy administration route in treating HER2-positive breast cancer (for patients, healthcare professionals, and healthcare system): a systematic literature review.
Luciana Castro Garcia Landeiro, Tamie de Camargo Martins, Ruth Bartelli Grigolon, Isabel Monteiro, Joana Bisol Balardin, Gilberto Amorim

Front Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond October, Beyond Pink: A Year-Round Revelation for Women's Breast Health.
Rakesh Kumar, Mabel Mardones, Luis Costa, Sunil Saini, Cynthia Villarreal-Garza, Gilberto Amorim

J Womens Health (Larchmt)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and healthcare resource utilization for triple negative breast cancer in the Brazilian private healthcare system: a database study.
Maria Amelia Carlos Souto Maior Borba, Paula de Mendonça Batista, Milena Falcão Almeida, Maria Aparecida do Carmo Rego, Fernando Brandão Serra, Gilberto Amorim

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2- advanced breast cancer: a Brazilian public health care system perspective.
Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Sergio D Simon, Gilberto Amorim, Tomás Reinert

Ther Adv Med Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence.
Francisco Pimentel Cavalcante, Edson Abdala, Leonardo Weissmann, Carlos Eduardo Dos Santos Ferreira, Gilberto Amorim

JCO Glob Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01).
Ana Lluch, Carlos H Barrios, Laura Torrecillas, Manuel Ruiz-Borrego, Jose Bines, Gilberto Amorim

J Clin Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System.
Márcio Debiasi, Tomás Reinert, Rafael Kaliks, Gilberto Amorim, Maira Caleffi

J Glob Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer.
Maria de Fátima Dias Gaui, Gilberto Amorim, Roberto Alfonso Arcuri, Guilherme Pereira, Denise Moreira

Am J Clin Oncol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis